Lv2
110 积分 2024-03-02 加入
Efficacy and safety of fulvestrant combined with abemaciclib in patients with hormone receptor-positive advanced breast cancer
3个月前
已关闭
Treatment advances across the cervical cancer spectrum
8个月前
已完结
The antibody–drug conjugate landscape
8个月前
已完结
The antibody–drug conjugate landscape
8个月前
已完结
Exploring the next generation of antibody–drug conjugates
8个月前
已完结
Antibody–drug conjugates come of age in oncology
8个月前
已完结
皖公网安备34019202002308
